Published in Sleep on July 01, 2012
The neural correlates of dreaming. Nat Neurosci (2017) 1.41
Consciousness in humans and non-human animals: recent advances and future directions. Front Psychol (2013) 1.10
Dreaming as mind wandering: evidence from functional neuroimaging and first-person content reports. Front Hum Neurosci (2013) 1.01
Virtual reality and consciousness inference in dreaming. Front Psychol (2014) 0.91
Selection of preconfigured cell assemblies for representation of novel spatial experiences. Philos Trans R Soc Lond B Biol Sci (2013) 0.85
Reporting dream experience: Why (not) to be skeptical about dream reports. Front Hum Neurosci (2013) 0.85
Alpha reactivity to first names differs in subjects with high and low dream recall frequency. Front Psychol (2013) 0.85
Why are dreams interesting for philosophers? The example of minimal phenomenal selfhood, plus an agenda for future research. Front Psychol (2013) 0.84
Increased lucid dreaming frequency in narcolepsy. Sleep (2015) 0.80
Psychosis and the Control of Lucid Dreaming. Front Psychol (2016) 0.79
Time for actions in lucid dreams: effects of task modality, length, and complexity. Front Psychol (2014) 0.79
Lucid dreaming in narcolepsy. Sleep (2015) 0.79
Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis. J Reward Defic Syndr (2015) 0.79
Volitional components of consciousness vary across wakefulness, dreaming and lucid dreaming. Front Psychol (2014) 0.79
Brain basis of self: self-organization and lessons from dreaming. Front Psychol (2013) 0.78
What I make up when I wake up: anti-experience views and narrative fabrication of dreams. Front Psychol (2013) 0.78
Dreaming and the neurobiology of self: recent advances and implications for psychiatry. Front Psychol (2013) 0.78
Dreaming as a story-telling instinct. Front Psychol (2013) 0.78
The myth of cognitive agency: subpersonal thinking as a cyclically recurring loss of mental autonomy. Front Psychol (2013) 0.77
Terror and bliss? Commonalities and distinctions between sleep paralysis, lucid dreaming, and their associations with waking life experiences. J Sleep Res (2016) 0.76
Methodological considerations for the neurophenomenology of dreaming: commentary on Windt's "Reporting dream experience". Front Hum Neurosci (2014) 0.75
Sleep - more local and complex than previously thought? Front Neurol (2012) 0.75
A Survey Focusing on Lucid Dreaming, Metacognition, and Dream Anxiety in Medical Students. Noro Psikiyatr Ars (2016) 0.75
The precuneus: a review of its functional anatomy and behavioural correlates. Brain (2006) 13.48
Stereotaxic display of brain lesions. Behav Neurol (2000) 9.20
Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci (2000) 8.71
Neural correlates of consciousness in humans. Nat Rev Neurosci (2002) 3.28
Neuroimaging analyses of human working memory. Proc Natl Acad Sci U S A (1998) 3.28
Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron (2008) 3.23
The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci (2002) 2.69
Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature (1996) 2.40
Disturbed dreaming, posttraumatic stress disorder, and affect distress: a review and neurocognitive model. Psychol Bull (2007) 2.36
Metacognitive evaluation, self-relevance, and the right prefrontal cortex. Neuroimage (2004) 2.17
Evaluating self-generated information: anterior prefrontal contributions to human cognition. Behav Neurosci (2003) 1.97
Lucid dreaming: a state of consciousness with features of both waking and non-lucid dreaming. Sleep (2009) 1.71
Dreamed movement elicits activation in the sensorimotor cortex. Curr Biol (2011) 1.27
Lucid dreaming verified by volitional communication during REM sleep. Percept Mot Skills (1981) 1.05
Lucid dreaming treatment for nightmares: a pilot study. Psychother Psychosom (2006) 0.98
Stress and the brain: from adaptation to disease. Nat Rev Neurosci (2005) 9.48
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet (2007) 4.54
Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci (2009) 4.53
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet (2004) 3.91
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem (2004) 2.91
Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci (2003) 2.79
Correlates of alpha rhythm in functional magnetic resonance imaging and near infrared spectroscopy. Neuroimage (2003) 2.68
Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet (2010) 2.46
RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell (2007) 2.34
Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry (2010) 2.17
Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry (2011) 2.09
The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron (2011) 2.02
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol (2002) 1.97
Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science (2002) 1.93
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry (2009) 1.88
Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci (2008) 1.88
Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol Psychiatry (2009) 1.85
Development of the brain's default mode network from wakefulness to slow wave sleep. Cereb Cortex (2011) 1.79
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet (2008) 1.78
Illuminating the BOLD signal: combined fMRI-fNIRS studies. Magn Reson Imaging (2006) 1.71
Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci (2007) 1.70
Development of a large-scale functional brain network during human non-rapid eye movement sleep. J Neurosci (2010) 1.69
Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science (2011) 1.64
Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry (2006) 1.62
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One (2010) 1.62
EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units. Eur J Hum Genet (2010) 1.62
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science (2009) 1.61
Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry (2005) 1.61
The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol Psychiatry (2005) 1.57
Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron (2008) 1.57
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry (2002) 1.56
Increased stress reactivity is associated with reduced hippocampal activity and neuronal integrity along with changes in energy metabolism. Eur J Neurosci (2012) 1.54
The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.52
Sensitivity of newborn auditory cortex to the temporal structure of sounds. J Neurosci (2009) 1.51
Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology (Berl) (2010) 1.49
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol (2002) 1.47
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res (2008) 1.45
Editorial comment--cerebral near-infrared spectroscopy: how far away from a routine diagnostic tool? Stroke (2004) 1.45
Time-resolved multidistance near-infrared spectroscopy of the adult head: intracerebral and extracerebral absorption changes from moments of distribution of times of flight of photons. Appl Opt (2004) 1.44
Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker? Biol Psychiatry (2006) 1.44
P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet (2006) 1.42
Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci (2005) 1.40
Towards a standard analysis for functional near-infrared imaging. Neuroimage (2004) 1.39
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. J Clin Psychiatry (2015) 1.39
FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol Psychiatry (2011) 1.37
High-resolution optical functional mapping of the human somatosensory cortex. Front Neuroenergetics (2010) 1.34
Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry (2011) 1.33
A wearable multi-channel fNIRS system for brain imaging in freely moving subjects. Neuroimage (2013) 1.30
Spatiotemporal reconfiguration of large-scale brain functional networks during propofol-induced loss of consciousness. J Neurosci (2012) 1.28
Dreamed movement elicits activation in the sensorimotor cortex. Curr Biol (2011) 1.27
Altered processing of acoustic stimuli during sleep: reduced auditory activation and visual deactivation detected by a combined fMRI/EEG study. Neuroimage (2002) 1.26
Somatosensory activation of two fingers can be discriminated with ultrahigh-density diffuse optical tomography. Neuroimage (2011) 1.26
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov (2012) 1.22
Increased sleep pressure reduces resting state functional connectivity. MAGMA (2010) 1.21
Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet (2006) 1.20
Phase coherent averaging in magnetic resonance spectroscopy using interleaved navigator scans: compensation of motion artifacts and magnetic field instabilities. Magn Reson Med (2002) 1.20
Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci U S A (2003) 1.20
Long-term behavioral and neuroendocrine alterations following chronic social stress in mice: implications for stress-related disorders. Horm Behav (2007) 1.20
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry (2003) 1.19
Heritability of sleep electroencephalogram. Biol Psychiatry (2008) 1.19
Essential role of the unusual DNA-binding motif of BAG-1 for inhibition of the glucocorticoid receptor. J Biol Chem (2002) 1.19
Overweight and obesity affect treatment response in major depression. Biol Psychiatry (2007) 1.18
Depletion of the neural precursor cell pool by glucocorticoids. Ann Neurol (2010) 1.17
Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology (2004) 1.17
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol (2006) 1.17
Stimulus-induced and state-dependent sustained gamma activity is tightly coupled to the hemodynamic response in humans. J Neurosci (2009) 1.16
The fast optical signal--robust or elusive when non-invasively measured in the human adult? Neuroimage (2005) 1.16
Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology (2012) 1.16
Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci (2002) 1.15